تجاوز إلى المحتوى الرئيسي
العنوان الوكيل الحالة الدواء المرحلة رقم البروتوكول موقع الدراسة
An Open-Label Study in Adolescent and Adult Severe (Coagulation Factor Activity <1%) Hemophilia A or B Patients With or Without Inhibitors Comparing Standard Treatment to PF-06741086 Prophylaxis Pfizer Ongoing PF-06741086 3 B7841005 King Abdulaziz University Hospital (Jeddah)
Acute Effect of seaweed (Ecklonia cava extract) on blood glucose and insulin level in pre-diabetic patients: A double-blind randomized-controlled trial King Khalid University Hospital Ongoing Ecklonia cava extract 3 SW2020 King Khalid University Hospital (Riyadh)
A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes. GW Rejected Cannabidiol & Tetrahydrocannabivarin 2A GWZMD1190 KAUH-R
A Phase III, Multicenter, Randomized, parallel-group study to asses the efficacy and saftey of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus open lable octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly. Novartis Ongoing Pasireotide 3 CSOM230C2402 NGHA-R
A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06687234 AS ADD-ON THERAPY TO INFLIXIMAB IN ACTIVE ULCERATIVE COLITIS SUBJECTS WHO ARE NOT IN REMISSION (BUILD UC) Pfizer Completed PF-06687234 2A B7581002 NGHA-R
"A PHASE 2/3, MULTICENTER, MULTINATIONAL, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALXN1101 IN NEONATES WITH MOLYBDENUM COFACTOR DEFICIENCY (MOCD) TYPE A" Alexion Terminated ALXN1101( Cyclic pyranopterin monophosphate monohydrobromide dihydrate) 2/3 ALXN1101-MCD-202 KFMC
A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthma Novartis Completed QAW039/Fevipiprant 3 CQAW039A2316 KFMC
Use of high dose of Colistin in Multidrug Resistant Gram Negative infections. Randomized Controlled clinical Trial
King Saud Medical City
Completed Colistin
4 KSMC-12-13
King Saud Medical City
"AN OBSERVATIONAL, NON-INTERVENTIONAL,
MULTI-CENTER, MULTI-NATIONAL STUDY OF
PATIENTS WITH ATYPICAL HEMOLYTIC-UREMIC
SYNDROME
(AHUS REGISTRY)"
Alexion
Rejected 4 M11-001
N/A
"easypod connect: A regional, Multicentre, Observational study to evaluate Adherence
and Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment"
Merck Serono
Rejected 4 200104-534
King Khalid University Hospital (Riyadh)
عرض 1 - 10 من 360